Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteric-Coated Cholestyramine in Short Bowel Syndrome
NCT04046328Phase 2Terminated
- Sponsor
- Pharmascience
- Start
- Oct 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of cholestyramine in short bowel syndrome (SBS), sponsored by Pharmascience. Started Oct 2019; status: terminated.
02
Drugs
cholestyramine
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT04046328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046328.